Rotavirus-associated mild encephalopathy with a reversible splenial lesion (MERS)—case report and review of the literature

BMC Infectious Diseases

Andrew J. Prendergast¹  Cheuk Y. W. Tong⁴  Ian R. Morrison²  Christina Spyridou²  Konstantinos Karampatsas³ 

[1] Centre for Paediatrics, Blizard Institute, Queen Mary University of London, London, UK;Department of Paediatrics, The Royal London Hospital, Barts Health NHS Trust, London, UK;Queen’s Hospital, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK;Department of Virology, The Royal London Hospital, Barts Health NHS Trust, London, UK

关键词: Paediatrics;    MERS;    Corpus Callosum;    Central Nervous System Infection;    Encephalopathy;    Rotavirus;   

Others  :  1232856
DOI  :  10.1186/s12879-015-1192-5

 received in 2015-05-06, accepted in 2015-10-07,  发布年份 2015

【 摘 要 】

Background

Rotavirus is the most common cause of severe gastroenteritis in children under the age of 5 years worldwide. It is well recognised that rotavirus can cause signs and symptoms beyond the gastrointestinal tract, including neurological manifestations such as encephalopathy. Mild encephalopathy with a reversible splenial lesion (MERS) is a clinico-radiological syndrome that has been associated with rotavirus. We report a case of a 4-year-old boy with clinically mild encephalopathy, who had an isolated splenial lesion in the corpus callosum on neuroimaging, and rotavirus RNA detected in faeces. We use this case as an opportunity to review the literature on rotavirus-associated MERS.

Case presentation

A previously healthy 4-year-old boy presented with a 2-day history of vomiting, diarrhoea, and fever, complicated by reduced level of consciousness. Magnetic resonance imaging of the brain showed a marked hyperintensity in the splenium of the corpus callosum on T2 and diffusion-weighted images. Rotavirus genome was detected by polymerase chain reaction in a stool specimen, but not in the cerebrospinal fluid. The genotype was identified as G1P8. His clinical condition improved with gradual resolution of his symptoms. No neurological complications were evident upon discharge and the patient had no recurring symptoms or significant residual defects when followed up 2 months later.

Conclusion

MERS is a novel clinic-radiological syndrome first described in Japan. A transient splenial lesion with reduced diffusion that appears as a high signal intensity in diffusion-weighted MRI is the main diagnostic feature. Rotavirus is one of the most common agents associated with MERS, although to our knowledge only one previous case has been reported from Europe. The majority of patients appear to achieve full recovery following rotavirus-associated MERS, irrespective of treatment. This case, together with other published reports, supports the hypothesis that rotavirus-associated MERS is unlikely to be the result of direct viral invasion of the CNS. It has been suggested that MERS may be caused by intra-myelinic axonal oedema or local inflammatory cell infiltration; however, the pathogenesis remains incompletely understood.

【 授权许可】

   
2015 Karampatsas et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. WHO-coordinated Global Rotavirus Surveillance Network 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12(2):136-41.
• [2]Blutt SE, Matson DO, Crawford SE, Staat MA, Azimi P, Bennett BL et al.. Rotavirus antigenemia in children is associated with viremia. PLoS Med. 2007; 4(4): Article ID e121
• [3]Takanashi J. Wide range of CNS manifestations of rotavirus infection. Brain Dev. 2011; 33(1):9.
• [4]Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H et al.. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology. 2004; 63:1854-8.
• [5]Morioka S, Otabe O, Uehara H, Yokoi K, Ohmizono Y, Ishimaru Y et al.. Recurrence of transient splenial lesions in a child with "benign convulsions with gastroenteritis". No To Hattatsu. 2010; 42(6):449-53.
• [6]Hoshino A, Saitoh M, Oka A, Okumura A, Kubota M, Saito Y et al.. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev. 2012; 34(5):337-43.
• [7]Takanashi J. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev. 2009; 31(7):521-8.
• [8]Kobata R, Tsukahara H, Nakai A, Tanizawa A, Ishimori Y, Kawamura Y et al.. Transient MR Signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: value of diffusion-weighted imaging. J Comput Assist Tomogr. 2002; 26(5):825-8.
• [9]Kato Z, Orii KE, Morimoto M, Sasai H, Funato M, Sawatari S et al.. A transient lesion in the corpus callosum during rotavirus infection. Pediatr Neurol. 2009; 41(6):467-9.
• [10]Fukuda S, Kishi K, Yasuda K, Sejima H, Yamaguchi S. Rotavirus-associated encephalopathy with a reversible splenial lesion. Pediatr Neurol. 2009; 40(2):131-3.
• [11]Arakawa C, Fujita Y, Imai Y, Ishii W, Kohira R, Fuchigami T et al.. Detection of group A rotavirus RNA and antigens in serum and cerebrospinal fluid from two children with clinically mild encephalopathy with a reversible splenial lesion. Jpn J Infect Dis. 2011; 64(3):204-7.
• [12]Natsume J, Naiki M, Yokotsuka T, Sofue A, Ikuta T, Kondo Y et al.. Transient splenial lesions in children with “benign convulsions with gastroenteritis”. Brain Dev. 2007; 29(8):519-21.
• [13]Yokoyama T, Yamada S, Doichi N, Kato E. Rotavirus-infected children with clinically mild encephalopathy with a reversible splenial lesion (MERS). BMJ Case Reports [online] Jul 16;2013. doi:10.1136/bcr-2013-008644
• [14]Mazur-Melewska K, Jonczyk-Potoczna K, Szpura K, Biegański G, Mania A, Kemnitz P et al.. Transient lesion in the splenium of the corpus callosum due to rotavirus infection. Childs Nerv Syst. 2015; 31:997-1000.
• [15]Fuchigami T, Goto K, Hasegawa M, Saito K, Kida T, Hashimoto K et al.. A 4-year-old girl with clinically mild encephalopathy with a reversible splenial lesion associated with rotavirus infection. J Infect Chemother. 2013; 19(1):149-53.
• [16]Jang YY, Lee KH. Transient splenial lesion of the corpus callosum in a case of benign convulsion associated with rotaviral gastroenteritis. Korean Journal of Pediatrics. 2010; 53(9):859-62.
• [17]Matsuoka T, Yodoshi T, Sugai M, Hiyane M, Matsuoka T, Akeda H et al.. A case of mild encephalopathy with a reversible splenial lesion associated with G5P[6]rotavirus infection. Case Reports in Pediatrics. 2013; 2013:197163.
• [18]18.Pan JJ, Zhao YY, Lu C, Hu YH, Yang Y. Mild encephalitis/encephalopathy with a reversible splenial lesion: five cases and a literature review. Neurol Sci. 2015 Jul 1. [Epub ahead of print]. doi:10.1007/s10072-015-2302-2
• [19]Kashiwagi M, Tanabe T, Shimakawa S, Nakamura M, Murata S, Shabana K et al.. Clinico-radiological spectrum of reversible splenial lesions in children. Brain Dev. 2014; 36(4):330-6.
• [20]Maeda M, Tsukahara H, Terada H, Nakaji S, Nakamura H, Oba H et al.. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol. 2006; 33(4):229-36.
• [21]Kazi AZ, Joshi PC, Kelkar AB, Mahajan MS, Ghawate AS. MRI evaluation of pathologies affecting the corpus callosum: A pictorial essay. The Indian Journal of Radiology & Imaging. 2013; 23(4):321-332.
• [22]Takanashi J, Miyamoto T, Ando N, Kubota T, Oka M, Kato Z et al.. Clinical and radiological features of rotavirus cerebellitis. Am J Neuroradiol. 2010; 31(9):1591-5.
• [23]Lynch M, Lee B, Azimi P, Gentsch J, Glaser C, Gilliam S et al.. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis. 2001; 33(7):932-8.
• [24]Nakagomi T, Nakagomi O. Rotavirus antigenemia in children with encephalopathy accompanied by rotavirus gastroenteritis. Arch Virol. 2005; 150(9):1927-31.
• [25]Gürtler S, Ebner A, Tuxhorn I, Ollech I, Pohlmann-Eden B, Woermann FG. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology. 2005; 65(7):1032-6.
• [26]Kallenberg K, Bailey DM, Christ S, Mohr A, Roukens R, Menold E et al.. Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab. 2007; 27(5):1064-71.
• [27]Miyata R, Tanuma N, Hayashi M, Imamura T, Takanashi J, Nagata R et al.. Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). Brain Dev. 2012; 34(2):124-7.
• [28]Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. 2001; 57(2):295-9.
• [29]Goldwater PN, Rowland K, Thesinger M, Abbott K, Grieve A, Palombo EA et al.. Rotavirus encephalopathy: Pathogenesis reviewed. J Paediatr Child Health. 2001; 37(2):206-9.
• [30]Kawashima H, Inage Y, Ogihara M, Kashiwagi Y, Takekuma K, Hoshika A et al.. Serum and cerebrospinal fluid nitrite/nitrate levels in patients with rotavirus gastroenteritis induced convulsion. Life Sci. 2004; 74(11):1397-405.
• [31]Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J et al.. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis. 2014; 58(2):173-7.
• [32]Tate JE, Haynes A, Payne DC et al.. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012. Pediatr Infect Dis J. 2013; 32(7):741-4.
• [33]Kneen R, Michael BD, Menson E, Mehta B, Easton A, Hemingway C et al.. On behalf of the National Encephalitis GuidelinesDevelopment and Stakeholder Groups. Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect. 2012; 64(5):449-77.
• [34]Ka A, Britton P, Troedson C, Webster R, Procopis P, Ging J et al.. Mild encephalopathy with reversible splenial lesion: An important differential of encephalitis. Eur J Paediatr Neurol. 2015; 19(3):377-82.